Last Updated: October 25, 2026
A plant name on a bottle is not a clinical dose, a finished-formula trial or a guarantee of gentle skincare. Botanical ingredients deserve the same questions as any other active: which extract, which route, which outcome and which comparison?
Medical disclaimer: This guide is educational, not a diagnosis or treatment plan. Acne, eczema, melasma and post-procedure skin need individualized care. Do not replace prescribed treatment or apply an unapproved cosmetic to a fresh wound or procedural site based on an ingredient name.
How to read this guide
Tier 1 means multiple randomized human trials for the specific outcome discussed; Tier 2 means limited human clinical evidence; Tier 3 means primarily mechanistic evidence; Tier 4 means the proposed clinical claim is not established by the evidence reviewed. These tiers apply to claims, not permanently to entire plants. A botanical can have clinical evidence for one outcome without being established for another.
Standardization matters. Kongkaew et al. (2020), Journal of Cosmetic Science, found that weak reporting and lack of standardization limited the general application of centella trial findings. Kim et al. (2021), Phytotherapy Research, found different acne results for topical and oral green tea. Neither “centella” nor “green tea” is one universally interchangeable intervention. PMID: 33413787; PMID: 32812270.
Centella: clinical interest, not an automatic wound-care recommendation
Tier 1 for a limited wrinkle evidence base, with substantial applicability limits: Kongkaew et al. (2020), Journal of Cosmetic Science, reviewed five double-blind randomized controlled trials involving 172 Asian women. Studies evaluated centella or related constituents in different preparations and measured lip or periocular wrinkling. The review reported improvements but highlighted weak reporting and the absence of extract standardization. PMID: 33413787.
This does not make every cica toner, spicule product, mask or ampoule equivalent to the studied preparations. Nor does wrinkle research establish that a retail cosmetic treats acne, repairs every compromised barrier or is appropriate immediately after a procedure. A network comparison also should not be converted into a blanket claim that centella outperforms retinoids or other synthetic ingredients. Kongkaew et al. (2020), Journal of Cosmetic Science, PMID: 33413787.
Practical takeaway: Ask for the extract, constituent standardization and finished-formula evidence. Do not interpret “cica” as permission to use any delivery format on already irritated or recently treated skin.
Mugwort: a soothing reputation is not established eczema efficacy
Tier 4 for a general retail mugwort eczema-treatment claim in the evidence reviewed: Thandar et al. (2017), British Journal of Dermatology, reviewed topical herbal interventions for atopic eczema. Eight studies met inclusion criteria; the authors found insufficient evidence of efficacy for any topical herbal extract, with small cohorts and methodological problems. This is a broad herbal review with a search ending in 2014, not a current exhaustive mugwort-only assessment. It cannot establish that every newer mugwort preparation is ineffective, but it does not justify recommending the category as established eczema care. PMID: 27373699.
Safety evidence, case report rather than an efficacy tier: Haw et al. (2010), Contact Dermatitis, reported allergic contact dermatitis associated with Artemisia vulgaris. A case report cannot estimate how often this happens, but it contradicts the assumption that a botanical name guarantees freedom from allergy. Different Artemisia species and extracts should not be silently treated as identical. PMID: 20136887.
Practical takeaway: A mugwort-containing product may be a cosmetic choice, but do not assign it a universal eczema, acne or allergy-safe indication. Avoid the earlier shortcut of calling an unrelated mask “mugwort-adjacent” as if that established an ingredient or benefit.
Green tea: acne findings are route-specific
Tier 1 for pooled acne-lesion findings across randomized studies, not retail-serum equivalence: Kim et al. (2021), Phytotherapy Research, included five randomized controlled studies with 125 participants receiving experimental treatments and 122 controls. Pooled findings favored green tea extract for inflammatory lesions; topical subgroup findings were more favorable than the limited oral effects. Non-inflammatory lesion findings also depended on route. The authors called for further high-quality trials. PMID: 32812270.
The review supports interest in studied topical preparations, not a claim that tea drinking, every green-tea serum or every concentration treats acne equally. It also does not establish green tea as a sunscreen or as interchangeable with vitamin C for all outcomes. Kim et al. (2021), Phytotherapy Research, PMID: 32812270.
Our Beauty of Joseon Calming Serum with Green Tea and Panthenol is a multi-ingredient cosmetic option. The catalog's green-tea extract percentage is not a standardized EGCG dose, and the cited meta-analysis does not establish this finished serum as trial-equivalent or as a substitute for acne treatment.
Licorice: liquiritin is not every licorice extract
Tier 2, small split-face human study: Amer and Metwalli (2000), International Journal of Dermatology, studied a liquiritin cream on one side of the face and vehicle cream on the other in 20 women with epidermal melasma. Treatment was twice daily for four weeks, alongside advice about sun avoidance and/or sunscreen. The paper concerns a specified licorice constituent and a defined population, not every product labeled “licorice root.” PMID: 10809983.
Tier 4 for broad substitution or superior-tolerability claims: This study does not establish that all licorice extracts are equivalent to liquiritin, that they match prescription hydroquinone, or that adding niacinamide and tranexamic acid is always gentler or more effective. Glabridin, glycyrrhizin and liquiritin are not interchangeable names for one standardized treatment. Amer and Metwalli (2000), International Journal of Dermatology, PMID: 10809983.
Practical takeaway: Ask what was actually studied before assigning a melasma claim to a cosmetic. Persistent pigmentation should not automatically be self-diagnosed as melasma.
Resveratrol: read the formulation and comparator
Tier 2, defined clinical preparations: Farris et al. (2014), Journal of Drugs in Dermatology, reported baseline improvements with a topical blend containing resveratrol, baicalin and vitamin E. The blend does not isolate resveratrol's contribution. Rao et al. (2025), Frontiers in Aging, subsequently tested oral and topical trans-resveratrol in a four-group randomized trial. Combined treatment improved total wrinkle scores more than double placebo after eight weeks in healthy women aged 40 and older. PMID: 25607790; PMID: 41488277.
That is not proof that any resveratrol serum extends cellular lifespan, that vitamin C plus vitamin E plus resveratrol is universally synergistic, or that topical use alone reproduces the combined-treatment finding. Rao et al. (2025), Frontiers in Aging, PMID: 41488277.
Skin Memory Serum is listed as a resveratrol-containing multi-ingredient topical. Its advertised cellular-energy, response-time and percentage claims are not substantiated by these studies. See our topical resveratrol formula-evaluation checklist and resveratrol human-trial guide for the comparison details.
A practical botanical routine: one purpose, not five plant names
- Define the concern. Cosmetic feel, acne lesions, eczema symptoms and pigment changes are different targets. Do not count one study as support for all of them.
- Check the identity. Look for species, extract, standardized constituent and finished-formula details. “Natural” and “high percentage” are not substitutes for this information.
- Change one thing at a time. As a practical tracking choice, avoid introducing several botanicals together. Otherwise it is harder to tell which new product coincided with a benefit or reaction.
- Do not replace care with a stack. The studies here do not establish that combining centella, mugwort, green tea, licorice and resveratrol improves outcomes more than a simpler routine.
- Reassess unexpected reactions. Do not assume redness or itching is a necessary adjustment phase. The mugwort contact-dermatitis report illustrates why a plant ingredient should not carry an automatic safety guarantee. Haw et al. (2010), Contact Dermatitis, PMID: 20136887.
For a related route-comparison lesson, read our oral versus topical astaxanthin guide. For supplement-shopping questions, see the ingestible beauty guide; topical findings should not be transferred automatically to oral products.
Commercial disclosure: Veracil sells the two cosmetics below. They are optional examples, not finished products established by the cited studies to treat acne, eczema or melasma, repair procedural wounds or reverse cellular aging. No five-product botanical stack is recommended.
Honest limitations
This is a focused evidence map, not an exhaustive review of every plant preparation or every product. Small studies, inconsistent extracts, limited populations and different routes restrict generalization. A promising formula result cannot validate an entire botanical category. Kongkaew et al. (2020), Journal of Cosmetic Science, PMID: 33413787; Kim et al. (2021), Phytotherapy Research, PMID: 32812270.
The calibrated verdict
Confirmed only within studied outcomes and preparations: Multiple randomized studies provide supportive wrinkle evidence for centella preparations and acne-lesion evidence for topical green tea preparations. This does not confirm the effectiveness of every commercial formula or establish either as a universal treatment replacement. Kongkaew et al. (2020), Journal of Cosmetic Science, PMID: 33413787; Kim et al. (2021), Phytotherapy Research, PMID: 32812270.
Preliminary Confirm: Defined liquiritin and resveratrol interventions warrant interest, with small or formulation-specific human evidence. Amer and Metwalli (2000), International Journal of Dermatology, PMID: 10809983; Rao et al. (2025), Frontiers in Aging, PMID: 41488277.
Inconclusive: A universal mugwort eczema recommendation, a synergistic five-botanical routine or blanket superiority of natural over synthetic ingredients. The evidence reviewed does not establish those claims. Thandar et al. (2017), British Journal of Dermatology, PMID: 27373699; Kongkaew et al. (2020), Journal of Cosmetic Science, PMID: 33413787.
The best botanical choice is not the longest plant list. It is a clearly identified preparation with evidence relevant to your actual goal.
The Veracil Research Team
0 comments